We are live on ! Find out more
3C

325 Capital Portfolio holdings

AUM $419M
1-Year Est. Return 75.74%
This Fund
S&P 500
This Quarter Est. Return
+13.37%
1 Year Est. Return
+75.74%
3 Year Est. Return
+225.71%
5 Year Est. Return
10 Year Est. Return
AUM
$274M
AUM Growth
-$10.9M
Cap. Flow
-$16M
Cap. Flow %
-5.83%
Top 10 Hldgs %
96.56%
Holding
13
New
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
DBD icon
Diebold Nixdorf
DBD
+$3.58M

Top Sells

Rank Stock Value
1
APEI icon
American Public Education
APEI
+$15.8M
2
ATRO icon
Astronics
ATRO
+$3.8M

Sector Composition

Rank Sector Weight
1 Consumer Staples 24.53%
2 Industrials 22.66%
3 Healthcare 21.6%
4 Technology 14.4%
5 Communication Services 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APEI icon
1
American Public Education
APEI
$842M
$67.3M 24.53%
1,183,732
-344,771
-23% -$15.8M
ASTH icon
2
Astrana Health
ASTH
$1.88B
$45.1M 16.43%
1,839,076
BLBD icon
3
Blue Bird Corp
BLBD
$1.88B
$38.6M 14.07%
679,826
MGNI icon
4
Magnite
MGNI
$3.4B
$23.8M 8.68%
2,005,387
SPIR icon
5
Spire Global
SPIR
$535M
$23.6M 8.59%
1,875,000
MPAA icon
6
Motorcar Parts of America
MPAA
$218M
$22.3M 8.13%
2,018,795
DBD icon
7
Diebold Nixdorf
DBD
$2.29B
$18.3M 6.65%
242,084
+48,683
+25% +$3.58M
AIOT
8
PowerFleet Inc
AIOT
$409M
$11.8M 4.31%
3,837,410
LFCR icon
9
Lifecore Biomedical
LFCR
$172M
$8.04M 2.93%
2,162,466
BTMD icon
10
Biote Corp
BTMD
$45M
$6.14M 2.24%
4,548,127
MSAI icon
11
MultiSensor AI
MSAI
$11.8M
$6.12M 2.23%
662,248
TACT icon
12
Transact Technologies
TACT
$53.4M
$3.33M 1.21%
1,011,789
ATRO icon
13
Astronics
ATRO
$3.26B
-84,000
Closed -$3.8M

Similar funds

325 Capital's Q1 2026 Portfolio in Review

As of Q1 2026, 325 Capital held 13 positions worth $274M, down 3.8% from $285M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

325 Capital withdrew a net $16M in Q1 2026, closing 1 position and reducing 1 holding. Its most notable exit was Astronics, an estimated $3.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, 325 Capital added an estimated $3.58M to Diebold Nixdorf.

  • 325 Capital added most to Diebold Nixdorf in Q1 2026, an estimated $3.58M increase.
  • 325 Capital's biggest Q1 2026 reduction was American Public Education, cutting an estimated $15.8M.
  • 325 Capital fully exited Astronics in Q1 2026, selling an estimated $3.8M.
  • 325 Capital's ten largest holdings make up 97% of its $274M portfolio in Q1 2026.
  • 325 Capital opened 0 new positions and closed 1 in Q1 2026.
  • 325 Capital's portfolio value fell 3.8% quarter-over-quarter to $274M.

Based on 325 Capital's 13F filing for Q1 2026, filed 15 May 2026.